酵素結合免疫吸附檢測法(ELISA) 檢測市場報告：2031 年趨勢、預測與競爭分析

全球酵素結合免疫吸附檢測法(ELISA) 檢測市場前景光明，醫院和診斷中心、製藥和生物技術公司、學術研究中心和臨床實驗室市場都存在機會。全球酵素結合免疫吸附檢測法(ELISA) 市場預計在 2025 年至 2031 年期間的複合年成長率為 7.5%。該市場的主要驅動力是愛滋病毒、登革熱、肝炎、瘧疾和流感等感染疾病的日益流行，以及面臨多種感染疾病風險的老年人口的不斷增加。

• 根據類型，Lucintel 預測，多功能可攜式ELISA 將在預測期內見證最高成長，因為它具有便攜性和持續的技術進步。
• 在最終用途類別中，由於疾病盛行率不斷上升、個人化醫療需求不斷成長以及政府對 ELISA 檢測的支持不斷增加，預計醫院和診斷中心將繼續成為最大的細分市場。
• 從地區來看，由於老齡人口的快速成長、醫療設備的採用率不斷提高以及先進的醫療保健基礎設施的存在，預計北美將在預測期內繼續成為最大的地區。

酵素結合免疫吸附檢測法（ELISA）市場的策略性成長機會

ELISA 檢測市場為各種應用提供了多種策略成長機會。

• 疾病診斷：ELISA 檢測在診斷新興感染疾病的應用日益廣泛，因其能夠及時、特異性識別，因此具有巨大的成長潛力。
• 藥物開發研究：藥物開發研究：ELISA 測試在藥物開發中的應用日益廣泛，特別是在藥物動力學監測和治療標靶檢驗方面，這代表著醫學領域的寶貴機會。
• 環境監測：受監管壓力和環境問題的推動，ELISA 在環境污染物和毒素監測中的應用正在增加。
• 食品安全：隨著食品安全法規和消費者意識的不斷提高，ELISA 在食品檢測中檢測污染物和過敏原變得越來越重要。
• 臨床研究：ELISA 在生物標記的發現和檢驗中發揮關鍵作用，支持個人化醫療和標靶治療，從而開闢新的市場能力。

這些領域中 ELISA 的使用日益廣泛，推動著市場的成長。

酵素結合免疫吸附檢測法（ELISA）檢測市場促進因素與挑戰

影響 ELISA 檢測市場的因素有很多，包括技術、經濟和監管。我們在此分析關鍵促進因素與挑戰

推動酵素結合免疫吸附檢測法（ELISA）市場發展的因素如下：

• 技術進步：新型 ELISA 技術的發明和發展、自動化、靈敏度的提高等提高了測試的產量和準確性，從而推動了市場的發展。
• 疾病盛行率不斷上升：慢性病和感染疾病的盛行率不斷上升。這使得對有效、可靠的診斷工具（包括 ELISA 測試）的需求日益成長。
• 政府措施：政府的優惠政策以及對研究和醫療基礎設施的投資正在加強 ELISA 市場。
• 提高意識：人們對疾病早期診斷和個人化醫療的認知不斷提高，推動了 ELISA 測試的採用。
• 不斷增加的應用：包括臨床診斷和監測在內的更廣泛的應用正在創造新的市場機會。

酵素結合免疫吸附檢測法（ELISA）檢測市場挑戰：

• 成本高：先進的 ELISA 系統和試劑的成本可能會限制其在資源匱乏的環境中的應用。
• 監管障礙：對 ELISA 測試的核准和驗證的嚴格監管要求可能會延遲市場進入並增加開發成本。

這些市場促進因素和挑戰正在塑造 ELISA 市場並影響相關人員的策略決策。

目錄

第1章執行摘要

第2章全球酵素免疫分析法（ELISA）檢測市場：市場動態

• 簡介、背景和分類
• 供應鏈
• 產業驅動力與挑戰

第3章 2019年至2031年市場趨勢及預測分析

• 宏觀經濟趨勢（2019-2024）及預測（2025-2031）
• 全球酵素免疫分析法試驗 (ELISA) 檢測市場趨勢（2019-2024 年）及預測（2025-2031 年）
• 全球酵素免疫分析法試驗（ELISA）檢測市場類型
  • 夾心 ELISA
  • 間接 ELISA
  • 多功能可攜式ELISA
  • 競爭性 ELISA
• 全球酵素免疫分析法試驗（ELISA）檢測市場（依應用）
  • 免疫學
  • 疫苗研發
  • 感染疾病
  • 癌症
  • 蛋白質定量
  • 其他
• 全球酵素免疫分析法試驗（ELISA）檢測市場（依最終用途）
  • 醫院和診斷中心
  • 製藥和生物技術公司
  • 學術研究中心
  • 臨床實驗室
  • 其他

第4章2019年至2031年區域市場趨勢與預測分析

• 區域酵素免疫分析法試驗（ELISA）檢測市場
• 北美酵素免疫分析法試驗（ELISA）檢測市場
• 歐洲酵素免疫分析法試驗（ELISA）檢測市場
• 亞太地區酵素免疫分析法試驗（ELISA）檢測市場
• 世界其他地區的酵素免疫分析法試驗（ELISA）檢測市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球酵素免疫分析法試驗（ELISA）檢測市場成長機會（按類型）
  • 全球酵素免疫分析法試驗（ELISA）檢測市場的成長機會（按應用）
  • 全球酵素免疫分析法試驗（ELISA）檢測市場的成長機會（依最終用途分類）
  • 區域酵素免疫分析法試驗（ELISA）檢測市場的成長機會
• 全球酵素免疫分析法（ELISA）檢測市場的新趨勢
• 戰略分析
  • 新產品開發
  • 全球酵素免疫分析法（ELISA）檢測市場的產能擴張
  • 全球酵素免疫分析法(ELISA) 檢測市場的合併、收購與合資企業
  • 認證和許可

第7章主要企業簡介

• Ortho Clinical Diagnostics
• Thermos Fisher Scientific
• BioMerieux
• Sysmex Corporation
• F. Hoffmann-La Roche
• Danaher Corporation
• Quidel Corporation
• Bio-Rad Laboratories
• Siemens Healthineers
• Abbott Laboratories

The future of the global enzyme-linked immunosorbent assay (ELISA) tests market looks promising with opportunities in the hospital and diagnostic center, pharmaceutical and biotech company, academic research center, and clinical laboratory markets. The global enzyme-linked immunosorbent assay (ELISA) tests market is expected to grow with a CAGR of 7.5% from 2025 to 2031. The major drivers for this market are the growing prevalence of infectious diseases, such as HIV, dengue, hepatitis, malaria, influenza, and others, and the growing geriatric population who are at risk of developing several infections.

• Lucintel forecasts that, within the type category, multiple and portable ELISA is expected to witness the highest growth over the forecast period due to portability and on-going technological advancements.
• Within the end use category, hospitals and diagnostic centers will remain the largest segment due to the increasing prevalence of diseases, rising demand for personalized medicine, and growing government support for ELISA testing.
• In terms of regions, North America will remain the largest region over the forecast period due to a surge in geriatric population, rising penetration of medical devices, and presence of well-advanced healthcare infrastructure in this region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

The ELISA tests market is shaped by several key trends:

• High-Throughput Screening: Automation enables laboratories to adopt high-throughput screening, significantly speeding up sample processing and reducing turnaround times, thus enhancing productivity.
• Multiplex ELISA: The development of multiplex ELISA tests allows for the simultaneous detection of multiple targets, improving diagnostic accuracy and streamlining workflows by reducing the need for multiple tests.
• Integration with Digital Platforms: Increasing integration of ELISA systems with digital platforms for data management and analysis enhances result precision and reproducibility through advanced software solutions.
• Point-of-Care Testing (POCT): There is growing interest in portable and user-friendly ELISA devices for POCT, providing timely diagnostics, especially in remote or underserved areas.
• Personalized Medicine: ELISA technologies are being adapted for personalized medicine, enabling tailored diagnostic and therapeutic strategies based on individual patient profiles and genetic information.

These trends contribute to the efficiency, accuracy, and accessibility of ELISA tests, driving innovation across various healthcare and research applications.

Recent Developments in the Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

Technological innovations and the rising demand for accurate diagnoses are propelling growth in the ELISA test market. Key developments include:

• Automation Integration: Automated ELISA systems are transforming laboratory operations by increasing sample throughput and reducing human error, resulting in more consistent and reliable performance.
• Improved Sensitivity: Advancements in ELISA technology have significantly enhanced assay sensitivity, enabling the detection of low analyte levels and facilitating early disease diagnosis.
• Portable ELISA Devices: The emergence of portable ELISA devices expands testing capabilities beyond laboratories, allowing for seamless testing in remote or resource-limited settings.
• Customizable ELISA Kits: The market is seeing more customizable ELISA kits designed for specific research or disease targets, providing greater flexibility and precision in diagnostics.
• Sustainable Practices: Manufacturers are increasingly focusing on sustainable practices, aiming to reduce waste and use eco-friendly materials in the production of ELISA kits and reagents.

These advancements are enhancing diagnostic capabilities and expanding the scope of ELISA tests.

Strategic Growth Opportunities for Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

The ELISA tests market offers several strategic growth opportunities across various applications:

• Disease Diagnostics: Expanding the use of ELISA for diagnosing emerging and infectious diseases presents significant growth potential for timely and specific identification.
• Drug Development Studies: ELISA tests are increasingly utilized in drug development, particularly for monitoring pharmacokinetics and validating therapeutic targets, presenting a valuable opportunity in pharmaceuticals.
• Environmental Monitoring: ELISA applications in environmental monitoring for pollutants and toxins are growing, driven by regulatory pressures and environmental concerns.
• Food Safety: ELISA is becoming essential in food testing to detect contaminants and allergens, spurred by increasing food safety regulations and consumer awareness.
• Clinical Research: ELISA plays a critical role in biomarker discovery and validation, supporting personalized medicine and targeted therapies, thus opening new market capabilities.

The expansion of ELISA applications across these sectors is fueling market growth.

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Driver and Challenges

Factors influencing the ELISA tests market range from technological, and economic, to regulatory. Here is an analysis of some of the important drivers and challenges:

The factors responsible for driving the enzyme-linked immunosorbent assay (ELISA) tests market include:

• Technological Advancements: Invention and development of new ELISA technologies instance, automation and improved sensitivity-have raised the output and precision of the tests, hence driving market growth.
• Increased Disease Prevalence: There is now a greater incidence of chronic and infectious diseases. This, in turn, is driving demand for effective and reliable diagnostic tools, which include ELISA tests.
• Government Initiatives: Favorable government policies and investments in research and health infrastructure enhance the ELISA market.
• Rising Awareness: Growing awareness of early disease diagnosis and personalized medicine promotes increased adoption of ELISA tests.
• Increasing Applications: The broadening range of applications, including clinical diagnostics and monitoring, creates new market opportunities.

Challenges in the enzyme-linked immunosorbent assay (ELISA) tests market are:

• High Costs: The cost of advanced ELISA systems and reagents may limit their accessibility in resource-poor settings.
• Regulatory Hurdles: Stringent regulatory requirements for the approval and validation of ELISA tests can delay market entry and increase development costs.

These drivers and challenges are shaping the ELISA market and influencing strategic decisions among stakeholders.

List of Enzyme-Linked Immunosorbent Assay (ELISA) Tests Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies enzyme-linked immunosorbent assay (ELISA) tests companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the enzyme-linked immunosorbent assay (ELISA) tests companies profiled in this report include-

• Ortho Clinical Diagnostics
• Thermos Fisher Scientific
• BioMerieux
• Sysmex Corporation
• F. Hoffmann-La Roche
• Danaher Corporation
• Quidel Corporation
• Bio-Rad Laboratories
• Siemens Healthineers
• Abbott Laboratories

Enzyme-Linked Immunosorbent Assay (ELISA) Tests by Segment

The study includes a forecast for the global enzyme-linked immunosorbent assay (ELISA) tests market by type, application, end use, and region.

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type [Analysis by Value from 2019 to 2031]:

• Sandwich ELISA
• Indirect ELISA
• Multiple and portable ELISA
• Competitive ELISA

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application [Analysis by Value from 2019 to 2031]:

• Immunology
• Vaccine Development
• Infectious diseases
• Cancer
• Protein quantitation
• Others

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals and Diagnostic Centers
• Pharmaceutical and Biotech Companies
• Academic Research Centers
• Clinical Laboratories
• Others

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

The ELISA test market is rapidly evolving with technological advancements and growing diagnostic demands. Recent developments in key markets include:

• United States: Innovation is thriving, with various high-throughput ELISA systems enhancing efficiency and accuracy to meet diagnostic and research demands.
• China: There is a focus on developing low-cost ELISA tests to improve accessibility in both urban and rural areas, supported by government initiatives to strengthen public health infrastructure.
• Germany: Companies are incorporating automation and digitalization into ELISA technology, maximizing laboratory workflow benefits for diagnostics and research.
• India: The increasing manufacturing of ELISA kits in India is reducing reliance on imports, enhancing the cost-effectiveness and accessibility of diagnostic tools.
• Japan: Japan is leading in developing multiplex ELISA tests, capable of detecting multiple analytes simultaneously, thus improving disease detection and monitoring efficiency.

Features of the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

Market Size Estimates: Enzyme-linked immunosorbent assay (ELISA) tests market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Enzyme-linked immunosorbent assay (ELISA) tests market size by various segments, such as by type, application, end use, and region in terms of value ($B).

Regional Analysis: Enzyme-linked immunosorbent assay (ELISA) tests market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the enzyme-linked immunosorbent assay (ELISA) tests market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the enzyme-linked immunosorbent assay (ELISA) tests market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M&A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the enzyme-linked immunosorbent assay (ELISA) tests market by type (sandwich ELISA, indirect ELISA, multiple and portable ELISA, and competitive ELISA), application (immunology, vaccine development, infectious diseases, cancer, protein quantitation, and others), end use (hospitals and diagnostic centers, pharmaceutical and biotech companies, academic research centers, clinical laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type
  • 3.3.1: Sandwich ELISA
  • 3.3.2: Indirect ELISA
  • 3.3.3: Multiple and portable ELISA
  • 3.3.4: Competitive ELISA
• 3.4: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application
  • 3.4.1: Immunology
  • 3.4.2: Vaccine Development
  • 3.4.3: Infectious diseases
  • 3.4.4: Cancer
  • 3.4.5: Protein quantitation
  • 3.4.6: Others
• 3.5: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use
  • 3.5.1: Hospitals and Diagnostic Centers
  • 3.5.2: Pharmaceutical and Biotech Companies
  • 3.5.3: Academic Research Centers
  • 3.5.4: Clinical Laboratories
  • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region
• 4.2: North American Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 4.2.1: North American Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
  • 4.2.2: North American Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
• 4.3: European Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 4.3.1: European Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
  • 4.3.2: European Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
• 4.4: APAC Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 4.4.1: APAC Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
  • 4.4.2: APAC Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
• 4.5: ROW Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 4.5.1: ROW Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
  • 4.5.2: ROW Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type
  • 6.1.2: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application
  • 6.1.3: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use
  • 6.1.4: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region
• 6.2: Emerging Trends in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Ortho Clinical Diagnostics
• 7.2: Thermos Fisher Scientific
• 7.3: BioMerieux
• 7.4: Sysmex Corporation
• 7.5: F. Hoffmann-La Roche
• 7.6: Danaher Corporation
• 7.7: Quidel Corporation
• 7.8: Bio-Rad Laboratories
• 7.9: Siemens Healthineers
• 7.10: Abbott Laboratories